The Oxford Handbook of the Economics of the Biopharmaceutical Industry
(Sprache: Englisch)
This volume comprises 18 chapters by leading academics on the economics of the biopharmaceutical industry. Part one examines economic determinants of biopharmaceutical R&D including financing, regulation, and patents. Part two addresses major issues in...
Leider schon ausverkauft
versandkostenfrei
Buch
Fr. 266.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „The Oxford Handbook of the Economics of the Biopharmaceutical Industry “
This volume comprises 18 chapters by leading academics on the economics of the biopharmaceutical industry. Part one examines economic determinants of biopharmaceutical R&D including financing, regulation, and patents. Part two addresses major issues in pharmaceutical markets including pricing, price regulation, and promotion; insurance coverage and effects of patient cost-sharing; the health value of pharmaceuticals; and the endemic use of mergers, acquisitions,and alliances.
Klappentext zu „The Oxford Handbook of the Economics of the Biopharmaceutical Industry “
The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, withfewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with 18 chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costsfor other industries; the effects of safety and efficacy regulation by the Food and Drug Administration(FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developingcountries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines;and a review of the evidence on effects of mergers, acquisitions and alliances. Each chaptersummarizes the
... mehr
latest insights from theory and recent empirical evidence, and outlines important unanswered questions and areas for future research. Based on solid economics, it is nevertheless written in terms accessible to the general reader. The book is thus recommended reading for academic economists and non-economists, and for those in industry and policy who wish to understand the economics of this fascinating industry.
... weniger
Bibliographische Angaben
- 2012, 624 Seiten, Masse: 25,5 cm, Gebunden, Englisch
- Herausgegeben:Danzon, Patricia M.; Nicholson, Sean
- Verlag: Oxford University Press
- ISBN-10: 0199742995
- ISBN-13: 9780199742998
Sprache:
Englisch
Kommentar zu "The Oxford Handbook of the Economics of the Biopharmaceutical Industry"
0 Gebrauchte Artikel zu „The Oxford Handbook of the Economics of the Biopharmaceutical Industry“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "The Oxford Handbook of the Economics of the Biopharmaceutical Industry".
Kommentar verfassen